EWG Elevate’s Eli Lilly LLY Stock Holding History

EWG Elevate’s Portfolio LLY Stock Details LLY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-241	Closed	-$88.2K	–	451
2022 Q4	$88.2K	Buy	+241	New	+$85.4K	0.04%	126

Other funds holding LLY

Lilly Endowment Indiananapolis, Indiana $108B AUM 53.87% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

PNC Financial Services Group Pittsburgh, Pennsylvania $173B AUM 20.72% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

EWG Elevate's LLY Position: Q1 2023 in Review

EWG Elevate sold out of Eli Lilly (LLY) in Q1 2023, closing a stake of 241 shares — an estimated $88.2K sold.

EWG Elevate first reported a position in LLY in Q4 2022 and held it in 1 quarter. The position peaked at $88.2K in Q4 2022. 2,615 funds tracked by Wall St. Rank hold LLY as of Q1 2023.

EWG Elevate reported no remaining Eli Lilly position as of Q1 2023 after selling out during the quarter.
EWG Elevate sold 241 Eli Lilly shares in Q1 2023, an estimated $88.2K.
EWG Elevate first reported a position in Eli Lilly in Q4 2022 and held it in 1 quarter.
EWG Elevate's Eli Lilly position peaked at $88.2K in Q4 2022.
2,615 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2023.

Based on EWG Elevate's 13F filing for Q1 2023, filed 13 Apr 2023.